These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 3126593

  • 1. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS.
    Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
    [Abstract] [Full Text] [Related]

  • 2. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS, Jordan AM, Murphy WM.
    Prog Clin Biol Res; 1989 Mar; 310():215-36. PubMed ID: 2505268
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravesical therapy for bladder cancer.
    Soloway MS.
    Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment modalities in superficial bladder cancer.
    Irwin R, Zincke H, Droller MJ, Prout GR, Soloway MS.
    Semin Urol; 1989 Feb; 7(1 Suppl 1):1-12. PubMed ID: 2499916
    [No Abstract] [Full Text] [Related]

  • 13. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984 Feb; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 14. Intravesical therapy for superficial bladder cancer.
    Baselli EC, Greenberg RE.
    Oncology (Williston Park); 2000 May; 14(5):719-29; discussion 729-31, 734, 737. PubMed ID: 10853462
    [Abstract] [Full Text] [Related]

  • 15. Follow up of patients receiving treatment for superficial bladder cancer with mitomycin C and BCG.
    Soloway MS.
    Prog Clin Biol Res; 1990 May; 350():71-9. PubMed ID: 2117289
    [Abstract] [Full Text] [Related]

  • 16. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED.
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [Abstract] [Full Text] [Related]

  • 17. Bladder contracture: review for intravesical bacillus Calmette-Guerin complication.
    Hameed A, Sezian N, Thwaini A.
    Can J Urol; 2007 Dec; 14(6):3745-9. PubMed ID: 18163926
    [Abstract] [Full Text] [Related]

  • 18. Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C.
    Soloway MS, Perry A.
    J Urol; 1987 May; 137(5):871-3. PubMed ID: 3106653
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.